Documentation scienceplus.abes.fr version Bêta

À propos de : Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide
has manifestation of work
related by
Abstract
  • BACKGROUND. Optic neuropathy is a rare manifestation of systemic lupus erythematosus (SLE). In a previous series most patients with optic neuropathy in association with SLE had a final visual acuity of 20/200 or less despite corticosteroid therapy. METHODS. Three patients (five affected eyes) with severe retrobulbar optic neuropathy in association with SLE were treated promptly with intravenous cyclophosphamide and corticosteroids. RESULTS. All patients recovered excellent visual acuity. CONCLUSION. Although optic neuropathy in association with SLE might have several different aetiologies, intravenous cyclophosphamide should be strongly considered as a therapeutic alternative.
article type
publisher identifier
  • 96214
is part of this journal
PubMed ID
  • 9059246



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata